The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPcg Entertainment Plc Regulatory News (PCGE)

  • There is currently no data for PCGE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update

11 Jun 2018 07:44

RNS Number : 9371Q
PCG Entertainment plc
11 June 2018
 

 

11 June 2018

 

PCG Entertainment Plc

("PCGE", the "Company" or the "Group")

PCG Entertainment Plc / Index: AIM / Epic: PCGE / NEX: PCGE

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

 

Company update, proposed termination of

equity sharing facility and proposed fundraising

 

Company update

 

Following the update provided prior to the UK Investor Show on 11 April 2018 the Board of PCGE is today providing the following update on the Company's business.

 

1. Environmental technologies

 

The Company remains in discussion with Dubai based Cavitation Solutions Ltd ("Cavitation Solutions") to distribute their cavitation technology in China and elsewhere in Asia. Cavitation Solutions applied earlier in the year to become an official environmental solutions provider to the Regional Organization for the Protection of the Marine Environment ("ROPME") and the Marine Emergency Mutual Aid Centre ("MEMAC") to deal with various oil and other environmental pollutants throughout the Gulf region.

 

ROPME and MEMAC are non-profit organisations setup and paid for by all countries surrounding the Gulf, including: Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates. ROPME and MEMAC provide environmental services to all these countries and support the main ministries in combatting environmental problems. The main roles of the organisations are to protect the marine environment and to support Gulf Nations during times of emergencies relating to environmental problems occurring throughout the region. In order to support their activities, ROPME and MEMAC contract all their work to professional companies that meet their stringent standards for quality, safety and environmental excellence.

 

Following several weeks of auditing, on 29th April 2018 Cavitation Solutions was approved by ROPME and MEMAC to provide environmental solutions throughout the Middle East, including:

· Waste oil collection and processing 

· Oil spill and oil contamination cleanup 

· Contaminated and wastewater treatment 

· Remediation of contaminated land

· Environmental emergency response 

2. ChainZy Plc

 

The IPO process for ChainZy Plc ("ChainZy"), a platform which uses Distributed Smart Ledger Technology (sometimes known as blockchain) is progressing well. The Company continues its discussion with ChainZy on the possibility of ChainZy using PCGE's infrastructure in Asia to distribute its technology in the region and may involve PCGE making a pre-IPO investment in ChainZy Plc. Shareholders should note that Michael Mainelli, a Director of PCGE, is a shareholder and director of ChainZy. The Board continues to believe this is a major opportunity for PCGE.

 

3. Opportunities to utilise the Company's media and gambling licences

 

Discussions with a third party on the use of the Company's media and gambling licences for the broadcast of certain sporting events over the Internet in China continues.

 

Termination of the equity sharing arrangements

 

The Company announces that it has entered into an agreement (the "Agreement") with D-Beta One EQ, Ltd. ("D-Beta") pursuant to which, inter alia, the parties have agreed to suspend the monthly payments to be made for April, May and June 2018 ("Deferred Monthly Payments") in respect of the equity sharing facility (the "Equity Sharing Facility") entered into by the Company with D-Beta, which was announced by the Company on 18 August 2017. The net amount payable in respect of the Deferred Monthly Payments is currently anticipated to be £8,609.41 payable by the Company to D-Beta. The Agreement also provides, inter alia, that:

 

- purchasers will be sought for 97,999,999 existing ordinary shares of 0.1 pence each in the capital of the Company held by D-Beta (the "Sale Shares");

 

- subscribers will be sought for new ordinary shares of 0.1 p each (the "New Ordinary Shares") in the capital of the Company (the "Placing Shares") to raise gross proceeds of approximately £303,000;

 

- the sale of the Sale Shares is to be conditional on admission to trading on AIM of the Placing Shares;

 

- neither the sale of the Sale Shares nor the placing of the Placing Shares will be underwritten;

 

- subject to receipt by D-Beta of the net proceeds of the sale of the Sale Shares and receipt by the Company of the net proceeds of the issue of the Placing Shares in each case by 30 June 2018 the final amount to be paid by or to the Company as the case may be (the "Final Payment Amount") in order to terminate the Equity Sharing Facility will be agreed by the parties or determined by the Company's auditors and such amount will relate not only to the Deferred Monthly Payments but also to each further anticipated monthly payment to be made under the Equity Sharing Facility (each such further anticipated monthly payment being defined as a "Further Payment"). It is currently anticipated that the Final Payment Amount will be approximately £118,855 payable by the Company to D-Beta but the actual amount of the Final Payment Amount will depend on, inter alia, the price at which the Sale Shares are sold and the Placing Shares are subscribed; and

 

- in the event that the net proceeds of the Share Sale and the Placing are not received by D-Beta and the Company respectively by 30 June 2018 then the payment of the Monthly Deferred Payments will be deferred to July, August and September 2018 respectively and the payment of each Further Payment will be deferred by 3 months respectively.

 

Proposed fundraising

 

The Company announces that it is proposing to raise a total of £303,000 (before expenses) through the issue of 202,000,001 New Ordinary Shares at a placing price of 0.15 pence (the "Placing Price") per New Ordinary Share. In addition D-Beta proposes to arrange the sale of 97,999,999 existing ordinary shares in the capital of the Company at the Placing Price.

 

It is proposed that the net proceeds of the Placing will be used to accelerate PCGE's business strategy and to settle amounts due to D-Beta under the Equity Sharing Facility as referred to above.

 

Further announcements will be made in due course.

 

For more information on PCGE please visit the Company's website www.pcge.com.

 

Enquiries:

 

PCG Entertainment PLC

Richard Poulden, Chairman Tel: +44 207 812 0645

 

Allenby Capital Limited

(Broker, Corporate Adviser and Nominated Adviser)

Nick Naylor/Nick Harriss Tel: +44 203 328 5656

 

SVS Securities Limited

(Joint Broker)

Ben Tadd/Tom Curran Tel: +44 203 700 0100

 

Damson Communications

(Public Relations)

Abigail Stuart-Menteth/Amelia Hubert Tel: +44 20 7812 0645

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUAONRWNANARR
Date   Source Headline
1st Jul 20195:30 pmRNSPCG Entertainment
1st Jul 20193:00 pmRNSUpdate on Planned Acquisition
28th Jun 20199:00 amRNSChange of Adviser and Corporate Update
31st May 201912:50 pmRNSResignation of nominated adviser and broker
3rd May 20199:26 amRNSResignation of nominated adviser and broker
21st Mar 20197:30 amRNSSuspension - PCG Entertainment Plc
21st Mar 20197:00 amRNSNotice of suspension
15th Mar 20194:41 pmRNSSecond Price Monitoring Extn
15th Mar 20194:35 pmRNSPrice Monitoring Extension
14th Mar 20199:01 amRNSJudgement Against the Company
8th Mar 20194:40 pmRNSSecond Price Monitoring Extn
8th Mar 20194:35 pmRNSPrice Monitoring Extension
8th Mar 20192:05 pmRNSSecond Price Monitoring Extn
8th Mar 20192:00 pmRNSPrice Monitoring Extension
8th Mar 201911:05 amRNSSecond Price Monitoring Extn
8th Mar 201911:00 amRNSPrice Monitoring Extension
20th Feb 20192:28 pmRNSChange of Brokers
3rd Jan 201911:03 amRNSResult of AGM
28th Dec 20187:00 amRNSFinancial results for the six months to 30 Sep 18
17th Dec 20187:30 amRNSAcquisition of deferred shares
4th Dec 20185:08 pmRNSNotice of AGM - Correction
4th Dec 20181:03 pmRNSNotice of Annual General Meeting of Shareholders
27th Nov 20182:55 pmRNSHolding in Company
14th Nov 20189:27 amRNSHolding in Company
13th Nov 20182:07 pmRNSHolding in the Company
5th Nov 20187:00 amRNSPCGE Holding in the Company
19th Oct 20181:13 pmRNSHolding in the Company
3rd Oct 20187:00 amRNSAppointment of Jack Sun
31st Aug 20183:15 pmRNSFinal Results
3rd Aug 20183:53 pmRNSCompany Statement
31st Jul 20183:28 pmRNSHolding(s) in Company
31st Jul 20183:21 pmRNSTotal Voting Rights
20th Jul 20187:00 amRNSAppointment of PR/IR Adviser
11th Jun 20188:03 amRNSUpdate on Proposed Fundraising
11th Jun 20187:44 amRNSCompany Update
23rd May 20182:00 pmRNSPrice Monitoring Extension
17th Apr 20187:00 amRNSCompany Update
11th Apr 20189:48 amRNSPCG Entertainment presenting at UK Investor Show
27th Mar 20182:01 pmRNSAppointment of Broker
19th Mar 20187:00 amRNSChange of Company Secretary Name
8th Mar 201811:11 amRNSChange of Registered Office
5th Mar 20185:09 pmRNSAdmission to the NEX Exchange Growth Market
2nd Mar 20189:45 amRNSStatement re broker
28th Feb 20187:00 amRNSTotal Voting Rights
27th Feb 20183:46 pmRNSHolding in the Company
26th Feb 20184:31 pmRNSAdmission to the NEX Exchange Growth Market
23rd Feb 20184:24 pmRNSPDMR Disclosure
14th Feb 20184:22 pmRNSUpdate on Equity Sharing Agreement
29th Jan 20182:03 pmRNSPlacing of new ordinary shares
26th Jan 20184:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.